Expression of insulin-like growth factor-binding protein 6 complementary DNA alters neuroblastoma cell growth

Cancer Research

Volumn 58, Issue 8, 1998, Pages 1670-1676

  Grellier, Pascale ^a   De Galle, Brigitte ^a   Babajko, Sylvie ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 6; SOMATOMEDIN C;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL CYCLE; CELL GROWTH; CONTROLLED STUDY; CYTOFLUOROMETRY; FEMALE; IMMUNOBLOTTING; MOUSE; NEUROBLASTOMA; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROMOTER REGION;

ANIMALS; BLOOD PROTEINS; BLOTTING, WESTERN; CELL DIVISION; CULTURE MEDIA, SERUM-FREE; DNA, COMPLEMENTARY; DNA, NEOPLASM; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 6; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEUROBLASTOMA; RNA, NEOPLASM; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0032522834     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. El-Badry, O., Romanus, J., Helman, L., Cooper, M., Rechler, M., and Israel, M. Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II. J. Clin. Invest., 84: 829-839, 1989.
2. Stewart, C., and Rotwein, P. Growth, differentiation and survival: multiple physiological functions for insulin-like growth factors. Physiol. Rev., 76: 1005-1026, 1996.
3. Toretsky, J., and Helman, L. Involvement of IGF-II in human cancer. J. Endocrinol., 149: 367-372, 1996.
4. Baserga, R., Helman, L., and Roberts, J. C. Insulin-like growth factors and cancer. Ann. Intern. Med., 122: 54-59, 1995.
5. Sullivan, K., Castle, V., Hanash, S., and Feldman, E. Insulin-like growth factor II in the pathogenesis of human neuroblastoma. Am. J. Pathol., 147: 1790-1798, 1995.
6. DeMeyts, P., Wallach, B., Christoffersen, C., Urso, B., Gronskov, K., Latus, L-J., Yakushiji, F., Ilondo, M., and Shymko, R. The insulin-like growth factor-1 receptor. Hormone Res. (Basel), 42: 152-169, 1994.
7. Lau, M., Stewart, C., Liu, Z., Rotwein, P., and Stewart, C. Loss of the imprinted IGF-2/cation-independent mannose-6-phosphate receptor results in fetal overgrowth and perinatal lethality. Genes Dev., 8: 2953-2963, 1994.
8. Shimasaki, S., and Ling, N. Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5, and -6). Prog. Growth Factor Res., 3: 243-266, 1991.
9. Swisshelm, K., Ryan, K., Tsuchiya, K., and Sager, R. Enhanced expression of an insulin growth factor-like binding protein (mac 25) in senescent human mammary epithelial cells and induced expression with retinoic acid. Proc. Natl. Acad. Sci USA, 92: 4472-4476, 1995.
10. Oh, Y., Nagalla, S., Yamanaka, Y., Kim, H-S., Wilson, E., and Rosenfeld, R. Synthesis and characterization of insulin-like growth factor-binding protein (IGFBP)-7. J. Biol. Chem., 271: 30322-30325, 1996.
11. Cohick, W., and Clemmons, D. The insulin-like growth factors. Annu. Rev. Physiol., 55: 131-153, 1993.
12. Jones, J., and Clemmons, D. Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev., 61: 3-34, 1995.
13. Baxter, R. Circulating binding proteins for the insulin-like growth factors. Trends Endocrinol. Metab., 4: 91-96, 1993.
14. Murphy, L., and Barron, D. The IGFs and their binding proteins in murine development. Mol. Reprod. Dev., 35: 376-381, 1993.
15. Clemmons, D. IGF-binding proteins: regulation of cellular actions. Growth Regul., 2: 80-87, 1992.
16. Schofield, P., Zumkeller, W., Mahmood, A., Chevalier, G., Martnerie, C., and Perbal, B. Insulin-like growth factors and their binding proteins in the control of tumour cell growth. Pathol. Biol., 42: 908-909, 1994.
17. Werner, H., and LeRoith, D. The role of the insulin-like growth factor system in human cancer. Adv. Cancer Res., 68: 183-223, 1996.
18. Villaudy, J., Delbe, J., Blat, C., Desauty, G., Golde, A., and Harel, L. An IGF binding protein is an inhibitor of FGF stimulation. J. Cell Physiol., 149: 492-496, 1991.
19. Booth, B., Bar, R., Roes, M., Dake, B., Bayne, D., and Cascieri, M. Intrinsic bioactivity of insulin-like growth factor-binding proteins from vascular endothelial cells. Endocrinology. 127: 2630-2638, 1990.
20. Andress, D., and Birnbaum, R. Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. J. Biol. Chem., 267: 22457-22472, 1992.
21. Cohen, P., Lamson, G., Okajima, T., and Rosenfeld, R. Transfection of the human insulin-like growth factor binding protein-3 gene into balb/c fibroblasts inhibits cellular growth. Mol. Endocrinol., 7: 380-386, 1993.
22. Oh, Y., Müller, H., Lamson, G., and Rosenfeld, R. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. J. Biol. Chem., 268: 14964-14971, 1993.
23. Singh, P., Dai, B., Dhruva, B., and Widen, S. Episomal expression of sense and antisense insulin-like growth factor (IGF)-binding protein-4 complementary DNA alters the mitogenic response of a human colon cancer cell line (HT-29) by mechanisms that are independent of and dependent upon IGF-I. Cancer Res., 54: 6563-6570, 1994.
24. Lamson, G., Giudice, L., and Rosenfeld, R. insulin-like growth factor binding proteins: structural and molecular relationship. Growth Factors, 5: 19-28, 1991.
25. Roghani, M., Lassarre, C., Zapf, J., Povoa, G., and Binoux, M. Two insulin-like growth factor (IGF)-binding proteins are responsible for the selective affinity for IGF-II of cerebrospinal fluid binding proteins. J. Clin. Endocrinol. Metab., 73: 658-666, 1991.
26. Bach, L., Thotakura, N., and Rechler, M. Human insulin-like growth factor binding protein-6 is glycosylated. Biochem. Biophys. Res. Commun., 186: 301-307, 1992.
27. Hynes, M., Brooks, P., Van Wyk, J., and Lund, K. Insulin-like growth factor II messenger ribonucleic acids are synthesized in the choroide plexus of the rat brain. Mol. Endocrinol., 2: 47-54, 1988.
28. Zhou, Y., Mohan, S., Linkhart, T., Baylink, D., and Strong, D. Retinoic acid regulates insulin-like growth factor-binding protein expression in human osteoblast cells. Endocrinology, 137: 975-983, 1996.
29. Gabbitas, B., and Canalis, E. Retinoic acid stimulates the transcription of insulin-like growth factor-binding protein-6 in skeletal cells. J. Cell. Physiol., 169: 15-22, 1996.
30. Gabbitas, B., and Canalis, E. Cortisol enhances the transcription of insulin-like growth factor-binding protein-6 in cultured osteoblasts. Endocrinology, 137: 1687-1692, 1996.
31. Babajko, S., Leneuve, P., Loret, C., and Binoux, M. IGFBP-6 is involved in growth inhibition in SH-SY5Y human neuroblastoma cells. Its production is both IGF- and cell density-dependent. J. Endocrinol., 152: 221-227, 1997.
32. Drivdahl, R., Loop, S., Andress, D., and Ostenson, R. IGF-binding proteins in human prostate tumor cells: expression and regulation by 1,25-dihydroxyvitamin D3. Prostate, 26: 72-79, 1995.
33. Babajko, S., and Binoux, M. Modulation by retinoic acid of insulin-like growth factor (IGF) and IGF-binding protein expression in human SK-N-SH neuroblastoma cells. Eur. J. Endocrinol., 134: 474-480, 1996.
34. Bernardini, S., Cianfarani, S., Spagnoli, A., Annicchiarico-Petruzzelli, M., Melino, G., Massoud, R., Boscherini, B., Finazzi-Agro, A., Rosenfeld, R., and Federici, G. Expression and down-regulation by retinoic acid of IGF-binding protein-2 and -4 in medium from human neuroblastoma cells. J. Neuroendocrinol., 6: 409-413, 1994.
35. Cianfarani, S., Germani, D., Rossi, P., Spagnoli, A., and Mercanti, D. Do insulin-like growth factor-binding proteins (IGFBPs) modulate the IGF-I growth-promoting and differentiating effects in human neuroblastoma cells? Eur. J. Endocrinol., 135: 716-723, 1996.
36. El-Badry, O., Helman, L., Chatten, J., Steinberg, S., Evans, A., and Israel, M. Insulin-like growth factor II-mediated proliferation of human neuroblastoma. J. Clin. Invest., 87: 648-657, 1991.
37. Martin, D., Singleton, J., Meghan, M., and Feldman, E. IGF receptor function and regulation in autocrine human neuroblastoma cell growth. Regul. Pept. 48: 225-232, 1993.
38. Leventhal, P., Randolph, A., Vesbit, T., Schenone, A., Windebank, A., and Feldman, E. Insulin-like growth factor-II as a paracrine growth factor in human neuroblastoma cells. Exp. Cell Res., 221: 179-186, 1995.
39. Singleton, J., Randolph, A., and Feldman, E. Insulin-like growth factor 1 receptor prevents apoptosis and enhances neuroblastoma tumorigenesis. Cancer Res., 56: 4522-4529, 1996.
40. Suarez, A., Hartmann, O., Vassal, G., Giron, A. G., Habrand, J., Valteau, D., Brugières, L., Kalifa, C., and Lemerle, J. Treatment of stage IV-S neuroblastoma: a study of 34 cases treated between 1982 and 1987. Med. Ped. Oncol., 19: 473-477, 1991.
41. El-Badry, O., Meyers, M., Spengler, B., Chang, T-D., Ross, R., and Biedler, J. Medium conditioned by human neuroblastoma BE(2)-C cells contains an autocrine/ paracrine acting growth factor with properties similar to insulin-like growth factor II. Adv. Neuroblast. Res., 3: 257-266, 1991.
42. Ferrandis, E., Da Silva, J., Riou, G., and Bénard, J. Coactivation of the MDK1 and MYCN genes in human neuroblastoma cells during the metastatic process in the nude mouse. Cancer Res., 54: 2256-2261, 1994.
43. Biedler, J., Helson, L., and Spengler, B. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res., 33: 2643-2652, 1973.
44. Oh, Y., Müller, H., Lee, D., Fielder, P., and Rosenfeld, R. Characterization of the affinities of insulin-like growth factor (IGF)-binding proteins 1-4 for IGF-I, IGF-II, IGF/insulin hybrid, and IGF-I analogs. Endocrinology, 132: 1337-1343, 1993.
45. Babajko, S., Hardouin, S., Segovia, B., Groyer, A., and Binoux, M. Expression of insulin-like growth factor-binding protein-1 and -2 genes through the perinatal period in the rat. Endocrinology, 132: 2586-2592, 1993.
46. Maniatis, T., Fritsch, E., and Sambrook, J. Extraction, purification, and analysis of mRNA from eukaryotic cells. In: Molecular Cloning: A Laboratory Manual, pp. 188-209. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1982.
47. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65: 55-59, 1983.
48. Pahlman, S., Ruusala, A., Abrahamsson, L., Mattson, M., and Esscher, T. Retinoicacid-induced differentiation of cultured human neuroblastoma cells: a comparison with phorbol-ester-induced differentiation. Cell Differ., 14: 135-144, 1984.
49. Ishii, D., Wang, C., and Li, Y. Second messengers mediating gene expression essential to neunte formation directed by insulin-like growth factors. In: K. Mohan and D. LeRoith (eds.), Molecular Biology and Physiology of Insulin-like Growth Factors, pp. 361-378. New York: Plenum Press, 1991.
50. Recio-Pinto, E., and Ishii, D. Insulin and insulin-like growth factor receptors regulating neunte formation in cultured human neuroblastoma cells. J. Neurosci. Res., 19: 312-320, 1988.
51. Burke, T., and Vuk-Pavlovic, S. Insulin-like growth factor-I is a serum component stimulating growth of human neuroblastoma. In Vitro Cell. Dev. Biol., 29A: 391-394, 1993.
52. Martin, D., and Feldman, E. Regulation of insulin-like growth factor-II expression and its role in autocrine growth of human neuroblastoma cells. J. Cell. Physiol., 155: 290-300, 1993.
53. Rubini, M., Hongo, A., D'Ambrosio, C., and Baserga, R. The IGF-I receptor in mitogenesis and transformation of mouse embryo cells: role of receptor number. Exp. Cell Res., 230: 284-292, 1997.
54. Menouny, M., Binoux, M., and Babajko, S. Role of IGFBP-2 and its limited proteolysis in neuroblastoma cell proliferation. Modulation by TGF-β and retinoic acid. Endocrinology, 138: 683-690, 1997.
55. Kato, M., Ishizaki, A., Hellman, U., Wernstedt, C., Kyogoku, M., Miyazono, K., Heldin, C-H., and Funa, K. A human keratinocyte cell line produces two autocrine growth inhibitors, transforming growth factor-β and insulin-like growth factor binding protein-6, in a calcium- and cell density-dependent manner. J. Biol. Chem., 270: 12373-12379, 1995.
56. Ewton, D., and Florini, J. IGF-binding proteins-4, -5 and -6 may play specialized roles during L6 myoblast proliferation and differentiation. J. Endocrinol., 144: 539-553, 1995.
57. Manni, A., Badger, B., Wei, L., Zaenglein, A., Grove, R., Khin, S., Heitjan, D., Shimasaki, S., and Ling, N. Hormonal regulation of insulin-like growth factor II and insulin-like growth factor-binding protein expression by breast cancer in vivo: evidence for stromal epithelial interactions. Cancer Res., 54: 2934-2942, 1994.
58. Kiefer, M. C., Schmid, C., Waldvogel, M., Schläpfer, I., Futo, E., Masiarz, F., Green, K., Barr, P., and Zapf, J. Characterization of recombinant human insulin-like growth factor-binding proteins 4, 5, and 6 produced in yeast. J. Biol. Chem., 267: 12692-12699, 1992.
59. Schmid, C., Schläpfer, I., Keller, A., Waldvogel, M., Froesch, E., and Zapf, J. Effects of insulin-like growth factor (IGF) binding proteins (BPs)-3 and -6 on DNA synthesis of rat osteoblasts: further evidence for a role of auto-/paracrine IGF I but not IGF II in stimulating osteoblast growth. Biochem. Biophys. Res. Commun., 21: 242-248, 1995.
60. Rajah, R., Valentinis, B., and Cohen, P. IGFBP-3 induces apoptosis and mediates the effects of transforming growth factor-β1 on programmed cell death through a p53-and IGF-independent mechanism. J. Biol. Chem., 272: 12181-12188, 1997.
61. Leal, S., Liu, Q., Huang, S., and Huang, J. The type V transforming growth factor β receptor is the putative insulin-like growth factor-binding protein 3 receptor. J. Biol. Chem., 272: 20572-20576, 1997.
62. Jaques, G., Noll, K., Wegmann, B., Witten, S., Kogan, E., Radulescu, R., and Havemann, K. Nuclear localization of insulin-like growth factor binding protein 3 in a lung cancer cell line. Endocrinology, 138: 1767-1770, 1997.